Delayed but sustained induction of mitogen-activated protein kinase activity is associated with β-adrenergic receptor-mediated morphological differentiation of astrocytes

Journal of Neurochemistry

Volumn 88, Issue 1, 2004, Pages 12-22

  Gharami, Kusumika ^a   Das, Sumantra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Astrocyte; Mitogen activated protein kinase; Morphology; Protein kinase A; Protein kinase C; adrenergic receptors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROPANOL;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR INTRINSIC ACTIVITY; STELLATE CELL;

ANIMALIA;

EID: 0347363614     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02148.x     Document Type: Article

References (97)

1. Abe K. and Saito H. (1997) Developmental changes in cyclic AMP-stimulated stellation of cultured rat cortical astrocytes. Jpn. J. Pharmacol. 75, 433-438.
2. Abe K. and Saito H. (2000) The p44/42 mitogen activated protein kinase cascade is involved in the induction and maintenance of astroglial stellation mediated by protein kinase C. Neurosci. Res. 36, 251-257.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M. and Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595.
4. Alessi D. R., Cuenda A., Cohen P., Dudley D. T. and Saltiel A. R. (1995a) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
5. Alessi D. R., Gomez N., Moorhead G., Lewis T., Keyse S. M. and Cohen P. (1995b) Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5, 283-295.
6. Allore R., O'Hanlon D., Price R., Neilson K., Willard H. F., Cox D. R., Marks A. and Dunn R. J. (1988) Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science 239, 1311-1313.
7. Aoki C. (1992) Beta-adrenergic receptors: astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry. J. Neurosci. 12, 781-792.
8. Beavo J. A., Bechtel P. J. and Krebs E. G. (1975) Mechanisms of control for cAMP-dependent protein kinase from skeletal muscle. Adv. Cyclic Nucleotide Res. 5, 241-251.
9. Blanco-Aparicio C., Torres J. and Pulido R. (1999) A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell. Biol. 147, 1129-1136.
10. Bornfeldt K. E. and Krebs E. G. (1999) Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal. 11, 465-477.
11. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S. and Pouyssegur J. (1999) Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674.
12. 125I]pindolol binding of individual astroglial cells. Brain Res. 335, 1-9.
13. Butcher R. W., Robison G. A., Hardman J. G. and Sutherland E. W. (1968) The role of cyclic AMP in hormone actions. Adv Enzyme Regul. 6, 357-389.
14. Cambray-Deakin M., Pearce B., Morrow C. and Murphy S. (1988) Effects of extracellular potassium on glycogen stores of astrocytes in vitro. J. Neurochem. 51, 1852-1859.
15. Chen J. and Iyengar R. (1994) Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s. Science 263, 1278-1281.
16. Cook S. J. and McCormick F. (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262, 1069-1072.
17. Crespo P., Cachero T. G., Xu N. and Gutkind J. S. (1995) Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. J. Biol. Chem. 270, 25259-25265.
18. Daaka Y., Luttrell L. M., Della Rocca G. J., Ferguson S. S. G., Caron M. G. and Lefkowitz R. J. (1998) Essential role for G protein coupled receptor endocytosis in the activation of mitogen activated protein kinase. J. Biol. Chem. 273, 685-688.
19. Duffy P. E., Rapport M. and Graf L. (1980) Glial fibrillary acidic protein and Alzhimer-type senile dementia. Neurology 30, 778-782.
20. Dugan L. L., Kimm J. S., Zhang Y., Bart R. D., Sun Y., Holtzman D. M. and Gutmann D. H. (1999) Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J. Biol. Chem. 274, 25842-25848.
21. Eng L. F. and Ghimikar R. S. (1994) GFAP and Astrogliosis. Brain Pathol. 4, 229-237.
22. Federoff S. (1986) Prenatal ontogenesis of astrocytes, in Astrocytes: Development, Morphology, and Regional Specialization of Astrocytes (Federoff S. and Vernadakis A., eds), Vol. 1, pp. 35-74. Orlando Academic Press, FL, USA.
23. Federoff S., McAuley W. A. J., Houle J. D. and Devon R. M. (1984) Astroglial cell lineage. V. Similarity of astrocytes that form in the presence of dbcAMP in cultures to reactive astrocytes in vivo. J. Neurosci. Res. 12, 15-27.
24. Gharami K. and Das S. (2000) Thyroid hormone-induced morphological differentiation and maturation of astrocytes are mediated through the beta-adrenergic receptor. J. Neurochem. 75, 1962-1969.
25. Gharami K. and Das S. (2003) Role of protein-tyrosine phosphatases on β-adrenergic receptor mediated morphological differentiation of astrocytes. J. Chem. Neuroanat. 26, 125-132.
26. Gicovate D. G. and Berria M. I. (1996) Age-dependent morphological changes in dBcAMP-treated astrocytes. Medicina (B. Aires) 56, 389-392.
27. Glass D., Masdracchia R., Feramisco J. and Kemp B. (1978) Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal. Biochem. 87, 566-577.
28. Graves L. M., Bornfeldt K. E., Raines E. W., Potts B. C., Macdonald S. G., Ross R. and Krebs E. G. (1993) Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl Acad. Sci. USA 90, 10300-10304.
29. Grewal S. S., Horgan A. M., York R. D., Withers G. S., Banker G. A. and Stork P. J. (1999) Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J. Biol. Chem. 275, 3722-3728.
30. Guillery R. W. and Walsh C. (1987) Changing glial organisation relates to changing fiber order in the developing optic nerve of ferrets. J. Comp. Neurol. 265, 203-217.
31. Hansson E. (1988) Astroglia from defined brain regions as studied with primary cultures. Prog. Neurobiol. 30, 369-397.
32. Hasegawa S., Morioka M., Goto S., Korematsu K., Okamura A., Yano S., Kai Y., Hamada J. I. and Ushio Y. (2000) Expression of neuron specific phosphatase (STEP) in reactive astrocytes after transient forebrain ischemia. Glia 29, 316-329.
33. Hatton G. I., Luckman S. M. and Bicknell R. J. (1991) Adrenalin activation of beta 2-adrenoceptors stimulates morphological changes in astrocytes (pituicytes) cultured from adult rat neurohypophyses. Brain Res. Bull. 26, 765-769.
34. Huang N. K., Lin Y. W., Huang C. L., Messing R. O. and Chern Y. (2001) Activation of protein kinase A and atypical protein kinase C by A (2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J. Biol. Chem. 276, 13838-13846.
35. Jorgensen O. S., Brooksbank B. W. L. and Balazs R. (1990) Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J. Neurol. Sci. 98, 63-79.
36. Kao S., Jaiswal R. K., Kolch W. and Landreth G. E. (2001) Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276, 18169-18177.
37. Kurino M., Fukunaga K., Ushio Y. and Miyamoto E. (1996) Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J. Neurochem. 67, 2246-2255.
38. L'Allemain G. (1994) Deciphering the MAP kinase pathway. Prog. Growth Factor Res. 5, 291-334.
39. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
40. Lawler O. A., Miggin S. M. and Kinsella B. T. (2001) Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J. Biol. Chem. 276, 33596-33607.
41. Lewis T. S., Shapiro P. S. and Ahn N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-139.
42. Lhose M. J., Benovic J. L., Caron M. G. and Lefkowitz R. J. (1990) Multiple pathways of rapid beta2-adrenergic receptor desensitization. Delineation with specific inhibitors. J. Biol. Chem. 265, 3202-3209.
43. Lim R., Mitsunobu K. and Li W. K. (1973) Maturation-stimulation effect of brain extract and dibutyryl cyclic AMP on dissociated embryonic brain cells in culture. Exp. Cell Res. 79, 243-246.
44. Lombroso P. J., Naegele J. R., Sharma E. and Lerner M. (1993) A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J. Neurosci. 13, 3064-3074.
45. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. S. (1951) Protein measurement with the Folin-Phenol reagent. J. Biol. Chem. 193, 265-275.
46. Machida C. A., Bunzow J. R., Searles R. P., Van Tol H., Tester B., Neve K. A., Teal P., Nipper V. and Civelli O. (1990) Molecular cloning and expression of the rat beta1-adrenergic receptor gene. J. Biol. Chem. 265, 12960-12965.
47. de Magalhaes J. C., Andrade A. A., Silva P. N., Sousa L. P., Ropert C., Ferreira P. C., Kroon E. G., Gazzinelli R. T. and Bonjardim C. A. (2001) A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276, 38353-38360.
48. Majumdar S., Rossi M. W., Fujiki T., Phillips W. A., Disa S., Queen C. F., Johnston R. B. Jr, Rosen O. M., Corkey B. E. and Korchak H. M. (1991) Protein kinase C isotypes and signaling in neutrophils. Differential substrate specificities of a translocatable calcium- and phospholipid-dependent beta-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. J. Biol. Chem. 266, 9285-9294.
49. Marshall C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
50. Masters S. B., Sullivan K. A., Miller R. T., Beiderman B., Lopez N. G., Ramachandran J. and Bourne H. R. (1988) Carboxyl terminal domain of Gs alpha specifies coupling of receptors to stimulation of adenylyl cyclase. Science 241, 448-451.
51. McCarthy K. D., Prime J., Harmon T. and Pollenz R. (1985) Receptor mediated phosphorylation of astroglial intermediate filament proteins in cultured astroglia. J. Neurochem. 44, 723-730.
52. Michell B. J., Chen Z. P., Tiganis T., Stapleton D., Katsis F., Power D. A., Sim A. T. and Kemp B. E. (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J. Biol. Chem. 276, 17625-17628.
53. Miyata S., Furuya K., Nakai S., Bun H. and Kiyohara T. (1999) Morphological plasticity and rearrangement of cytoskeletons in pituicytes cultured from adult rat neurohypophysis. Neurosci. Res. 33, 299-306.
54. Morin D., Sapena R., Zini R., Onteniente B. and Tillement J. P. (1997) Characterization of beta-adrenergic receptors of freshly isolated astrocytes and neurons from rat brain. Life Sci. 60, 315-324.
55. Murphy S. and Pearce B. (1987) Functional receptors for neurotransmitters on astroglial cells. Neurosci. 22, 381-394.
56. New L., Li Y., Ge B., Zhong H., Mansbridge J., Liu K. and Han J. (2001) SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway. J. Cell. Biochem. 83, 585-596.
57. Norris J. G. and Benveniste E. N. (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. Neuroimmunology 45, 137-145.
58. Norton W. T., Aquino D. A., Hozuni I., Chiu F. C. and Brosnan C. F. (1992) Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17, 877-885.
59. Paul S., Das S., Poddar R. and Sarkar P. K. (1996) Role of thyroid hormone in the morphological differentiation and maturation of astrocytes: temporal correlation with synthesis and organization of actin. Eur. J. Neurosci. 8, 2361-2370.
60. Paul S., Gharami K., Das S. and Sarkar P. K. (1999) Thyroid hormone-induced maturation of astrocytes is associated with the expression of new variants of vimentin and their phosphorylation. J. Neurochem. 73, 1964-1972.
61. Paul S., Snyder G. L., Yokakura H., Picciotto M. R., Naim A. C. and Lombroso P. J. (2000) The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20, 5630-5638.
62. Pcsce L., Guerrero C., Comellas A., Ridge K. M. and Sznajder J. I. (2000) Beta-agonists regulate Na, K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways. FEBS Lett. 486, 310-314.
63. Pieroni J. P., Jacobowitz O., Chen J. and Iyengar R. (1993) Signal recognition and integration by Gs-stimulated adenylyl cyclases. Curr. Opin. Neurobiol. 3, 345-351.
64. Porter J. T. and McCarthy K. D. (1997) Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 51, 439-455.
65. Pulido R., Zuniga A. and Ullrich A. (1998) PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17, 7337-7350.
66. Rakic P. (1972) Mode of cell migration to the superficial layers of fetal monkey neocortex. J. Comp. Neurol. 145, 61-81.
67. Robinson M. J., Stippec S. A., Goldsmith E., White M. A. and Cobb M. H. (1998) A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150.
68. Rosenberg P. A., Knowles R., Knowles K. P. and Li Y. (1994) Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci. 14, 2953-2965.
69. Rosenblum K., Futter M., Voss K., Erent M., Skehel P. A., French P., Obosi L., Jones M. W. and Bliss T. V. (2002) The role of extracellular regulated kinases I/II in late-phase long-term potentiation. J. Neurosci. 22, 5432-5441.
70. Roy M. L. and Sonthemeimer H. (1995) Beta-adrenergic modulation of glial inwardly rectifying potassium channels. J. Neurochem. 64, 1576-1584.
71. Salm A. K. and McCarthy K. D. (1992) The evidence for astrocytes as a target for central noradrenergic activity: expression of adrenergic receptors. Brain Res. Bull. 29, 265-275.
72. Samuels N. H., Stanley F. and Casanova Z. (1979) Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105, 80-85.
73. Saxena M., Williams S., Tasken K. and Mustelin T. (1999) Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat. Cell Biol. 1, 305-311.
74. Schechter R., Yen S. H. C. and Terry R. D. (1981) Fibrous astrocytes in senile dementia of the Alzheimer type. J. Neuropathol. 40, 95-101.
75. Schmitt J. M. and Stork P. J. S. (2000) β2-Adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf. J. Biol. Chem. 275, 25342-25350.
76. Scwartz J. P. and Nishiyama N. (1994) Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 35, 403-407.
77. Seger R. and Krebs E. G. (1995) The MAPK signaling. FASEB J. 9, 726-735.
78. Sevetson B. R., Kong X. and Lawrence J. C. Jr (1993) Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA 90, 10305-10309.
79. Shain W., Forman D. S., Madelian V. and Turner J. N. (1987) Morphology of astroglial cells is controlled by beta-adrenergic receptors. J. Cell. Biol. 105, 2307-2314.
80. Shao Y. and Sutin J. (1992) Expression of adrenergic receptors in individual astrocytes and motor neurons isolated from the adult rat brain. Glia 6, 108-117.
81. Sharma S. K. and Raj A. B. (1987) Transient increase in intracellular concentration of adenosine 3′:5′-cyclic monophosphate results in morphological and biochemical differentiation of C6 glioma cells in culture. J. Neurosci. Res. 17, 135-141.
82. Silver J., Lorenz S. E., Wahlsten D. and Coughlin J. (1982) Axonal guidance during development of the great cerebral commissures: descriptive experimental studies, in vivo, on the role of preformed glial pathways. J. Comp. Neurol. 210, 10-29.
83. Slack D. N., Seternes O. M., Gabrielsen M. and Keyse S. M. (2001) Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J. Biol. Chem. 276, 16491-16500.
84. Stone E. A. and Ariano M. A. (1989) Are glial cells targets of the central noradrenergic system? A review of the evidence. Brain Res. Rev. 14, 297-309.
85. Strack S. (2002) Overexpression of the protein phosphatase 2A regulatory subunit B[gamma] promotes neuronal differentiation by activating the MAP kinase cascade. J. Biol. Chem. 77, 41525-41532.
86. Sugden P. H. and Clerk A. (1997) Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 9, 337-351.
87. Sung J. Y., Shin S. W., Ahn Y. S. and Chung K. C. (2001) Basic fibroblast growth factor-induced activation of novel CREB kinase during the differentiation of immortalized hippocampal cells. J. Biol. Chem. 276, 13858-13866.
88. Takahashi I., Kobayashi E., Nakano H., Murakata C., Saitoh H., Suzuki K. and Tamaoki T. (1990) Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C. J. Pharmacol. Exp. Ther. 255, 1218-1221.
89. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
90. Ueki T., Fujita M., Sato K., Asai K., Yamada K. and Kato T. (2001) Epidermal growth factor down-regulated connexin-43 expression in cultured ray cortical astrocytes. Neurosci. Lett. 313, 53-56.
91. Van Den Maagdenberg A. M., Bachner D., Schepens J. T., Peters W., Fransen J. A., Wieringa B. and Hendriks W. J. (1999) The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development. Eur. J. Neurosci. 11, 3832-3844.
92. Vogt Weisenhorn D. M., Roback L. J., Kwon J. H. and Wainer B. H. (2001) Coupling of cAMP/PKA and MAPK signaling in neuronal cells is dependent on developmental stage. Exp. Neurol. 169, 44-55.
93. Wu J., Dent P., Jelinek T., Wolfman A., Weber M. J. and Sturgill T. W. (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262, 1065-1068.
94. Yao H., York R. D., Misra-Press A., Carr D. W. and Stork P. J. (1998) The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273, 8240-8247.
95. Yu S. S., Lefkowitz R. J. and Hausdorff W. P. (1993) Molecular cloning and expression of the rat beta1-adrenergic receptor gene. J. Biol. Chem. 268, 337-341.
96. Zou Y., Komuro I., Yamazaki T., Kudoh S., Uozumi H., Kadowaki T. and Yazaki Y. (1999) Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J. Biol. Chem. 274, 9760-9770.
97. Zuniga A., Torres J., Ubeda J. and Pulido R. (1999) Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J. Biol. Chem. 274, 21900-21907.